eTMF market to grow sizably over next three years, ISR reports

By Melissa Fassbender

- Last updated on GMT

(Image: iStock/ArtemSam)
(Image: iStock/ArtemSam)
The adoption of eTMF solutions is accelerating – with more than 50% of investigative sites expected to have access to a sponsor/CRO eTMF application within three years.

This figure is according to a recent report​ published by Industry Standard Research (ISR), which assessed eTMF (electronic trial master file) application access to be around 20% today.

Andrew Schafer, President, Industry Standard Research (ISR) said the driving demand is “simply an evolution​” of pharmaceutical and service providers to web-based applications.

Schafer compared the shift in the market to the adoption curve of other eClinical technologies, such as EDC, eCOA, ePRO, and IRT/IVR.

Based on those services and what we have witnessed, early and high market penetration is key to long-term success in these markets​,” he told us. “There are certainly clear leadership positions being established, but there is also a segment of providers that can easily climb into the top share positions​.”

According to the report, survey respondents – including both pharma and CROs – recently interacted with two eTMF systems.

It will be interesting, if the data hold and sites gain more access to CRO/sponsor eTMF systems, then sites will quickly be ‘burdened’ with having to navigate many more eTMF systems, just as they do with EDC systems today​,” said Schafer.

Related news

Show more

Related products

show more

Saama accelerates data review processes

Saama accelerates data review processes

Content provided by Saama | 25-Mar-2024 | Infographic

In this new infographic, learn how Saama accelerates data review processes. Only Saama has AI/ML models trained for life sciences on over 300 million data...

More Data, More Insights, More Progress

More Data, More Insights, More Progress

Content provided by Saama | 04-Mar-2024 | Case Study

The sponsor’s clinical development team needed a flexible solution to quickly visualize patient and site data in a single location

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us


View more